Financial Daily from THE HINDU group of publications
Thursday, Oct 20, 2005


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Corporate Results - Pharmaceuticals


Lupin net up on higher sales

Our Bureau

MUMBAI: Lupin Ltd has posted a 158 per cent growth in net profit for the three-month period ended September 30, 2005. The company clocked a net profit of Rs 45.2 crore for the quarter compared to Rs 17.5 crore for the same quarter in the previous fiscal.

The profitability was driven by higher sales in both the finished dosage and bulk drug businesses across different markets, the company said in a statement issued after its board meeting on Wednesday.

Total income (net of excise) has increased to Rs 414 crore in the current quarter. It was Rs 303.19 crore in the same period last fiscal.

The company's board also approved a proposal to raise funds up to $100 million through Foreign Currency Convertible Bonds, the company told the BSE.

The company has also announced that economist Dr Vijay Kelkar and Mr R. A. Shah have joined the board as independent directors.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Tata Safari Dicor

Stories in this Section
Wipro Consumer Care revenues grow 24%


Clariant net profit up 37 pc
Gujarat Ambuja Cements consolidated net up 7 pc
Coromandel Fert Q2 net profit doubles
Godavari Fert net profit rises
Biocon Q2 net down 29 pc — Tax outgo, European statins market hit profits
Wockhardt Q3 net rises 30 pc
Lupin net up on higher sales
Reliance Energy Q2 net up 24 pc on higher sales
Varun Shipping Q2 net up at Rs 43 cr
Wipro posts 16 pc rise in Q2 net — Revenues for the quarter beat guidance
Infotech Enterprises Q2 revenue, net up
HCL Info net up 44 pc at Rs 62 cr
Pidilite posts higher net
Himatsingka Seide net rises 15%
Blue Dart Q2 profit rises to Rs 17.66 cr


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line